Skip to main content
. 2015 Nov 2;112(46):E6359–E6368. doi: 10.1073/pnas.1516394112

Table 1.

MDS patient characteristics and summary of results

Patient no. Age, y MDS subtype Karyotype Hemoglobin, g/dL Clonal cells (FISH), % Actin disruption, % GlyA (day 14), %
MDS 1 60 RCMD −7 6 18.53 91.7 80.67
MDS2 67 RA −7 8 2.96 77.7 98.7
MDS 3 70 RAEB −7 6.6 66.67 93 2.7
MDS 4 83 RA −7 7 12.26 50.2 90
MDS 5 67 RCMD −7 6.7 10.15 24.9 97.9
MDS 6 77 RCMD Complex −7 11.4 10 82.14 65.6
MDS 7 63 RCMD Complex −7 12.7 35 52.8 55.5
MDS 8 75 RCMD Complex −7 9.8 5.5 77.7 56.7
MDS 9 84 RAEB Complex −7 7.6 6 50.37 59.9
MDS 10 74 RCMD Complex −7 12 7.75 79.6 51

RAEB, RA with excess blasts; RCMD, refractory cytopenias with multilineage dysplasia.